Advancing Obesity Management: From Current Guidelines to Amylin and GLP-1 Combination Breakthroughs

    Dates:
    Organizer:
    Saudi Scientific Diabetes Society (SSDS) — Obesity Connect 360
    Location:
    Online via Zoom
    Specialty:
    Endocrinology
    Format:
    Online

    Advancing Obesity Management: From Current Guidelines to Amylin and GLP-1 Combination Breakthroughs is an Obesity Connect 360 live webinar carrying the Saudi Scientific Diabetes Society identity. It takes place online on 26 November 2026, from 9:00 to 10:30 pm Saudi Arabia time (18:00–19:30 UTC). The organiser’s Zoom registration page confirms the event title and its 18:00 UTC start; the accompany

    Advancing Obesity Management: From Current Guidelines to Amylin and GLP-1 Combination Breakthroughs

    Advancing Obesity Management: From Current Guidelines to Amylin and GLP-1 Combination Breakthroughs1 / 1

    1 photo · tap to enlarge

    Advancing Obesity Management: From Current Guidelines to Amylin and GLP-1 Combination Breakthroughs

    Listed 22 Nov 2026

    About this event

    Advancing Obesity Management: From Current Guidelines to Amylin and GLP-1 Combination Breakthroughs is an Obesity Connect 360 live webinar carrying the Saudi Scientific Diabetes Society identity. It takes place online on 26 November 2026, from 9:00 to 10:30 pm Saudi Arabia time (18:00–19:30 UTC). The organiser’s Zoom registration page confirms the event title and its 18:00 UTC start; the accompanying official poster provides the complete 90-minute timetable.

    The programme examines obesity as a chronic disease and connects current management guidance with emerging approaches involving amylin and GLP-1 combinations. Its opening clinical session addresses current guidance and treatment goals, establishing the context for a subsequent discussion of the future of obesity care. These are the published educational topics, rather than a claim that any particular emerging treatment is approved, available locally or appropriate for an individual patient.

    Chair and faculty. Dr. Saud Al-Sifri chairs the webinar and delivers the opening session. The poster identifies him as Consultant Endocrinologist and Diabetes physician at Al Hada and Taif Armed Forces Hospitals in Taif. Dr. Sean Wharton, Medical Director of Wharton Medical Clinic in Canada, presents the session on amylin and GLP-1 combinations. The closing segment returns to Dr. Al-Sifri for a summary of the discussion and key takeaways.

    Published programme — all times Saudi Arabia (UTC+3):

    • 21:00–21:10: Welcome and objectives — Dr. Saud Al-Sifri.
    • 21:10–21:30: Obesity as a chronic disease — current guidance and treatment goals — Dr. Saud Al-Sifri.
    • 21:30–22:00: Shaping the future of obesity care: With Amylin and GLP-1 combination — Dr. Sean Wharton.
    • 22:00–22:15: Q&A discussion.
    • 22:15–22:30: Closing and key takeaways — Dr. Saud Al-Sifri.

    Registration is handled directly by the organiser through the Zoom link decoded from the poster’s QR code. The form requests attendee identity and professional details, including workplace, city, specialty and SCFHS number. No attendance fee is published in the supplied poster or accessible registration form, so free attendance is not assumed. The poster displays a generic CME-hours stamp but does not state a number of hours or name the approving body; consequently no verified accreditation award is claimed. No named commercial sponsor, workshop, abstract call or separate programme PDF is published in these sources.

    Ratings & Reviews

    No ratings yet
    FREE WEEKLY DIGEST

    Never miss a CME event

    Get curated events for your specialty — every week